Buscar
NovaBay Pharmaceuticals Inc
NBYAñadir a la lista de seguimiento
1.950USD
0.0000.00%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
68.61MCap. mercado
PérdidaP/E TTM
Más Datos de NovaBay Pharmaceuticals Inc Compañía
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Información de NovaBay Pharmaceuticals Inc
Símbolo de cotizaciónNBY
Nombre de la empresaNovaBay Pharmaceuticals Inc
Fecha de salida a bolsaOct 26, 2007
Director ejecutivoKazley (Michael John)
Número de empleados14
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 26
Dirección2000 Powell St Ste 1150
CiudadEMERYVILLE
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal94608-1804
Teléfono15108998800
Sitio Webhttps://novabay.com/
Símbolo de cotizaciónNBY
Fecha de salida a bolsaOct 26, 2007
Director ejecutivoKazley (Michael John)
Ejecutivos de NovaBay Pharmaceuticals Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de NovaBay Pharmaceuticals Inc?
Los cinco principales accionistas de NovaBay Pharmaceuticals Inc son: Ms. Swan Sit
¿Cuántas instituciones poseen acciones de NovaBay Pharmaceuticals Inc (NBY)?
A fecha de 2026Q1, 47 instituciones poseen acciones de NovaBay Pharmaceuticals Inc, con un valor de mercado combinado de aproximadamente 1.80M, lo que representa el 6.77% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 1464094.00.